Sort
78,016 grants matching “breast cancer”
Hydrogen Sulfide as a Radiosensitizer for Glioblastoma
$435,667Lynn Harrison · Louisiana State Univ Hsc Shreveport · R15 · FY2019 · CA
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines
$435,660Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Measurement of Aberrant Protein Folds in Malignant Cells with Proteomics and Mass Spectrometry
$435,649John Robert Yates · Scripps Research Institute, The · R33 · FY2017 · CA
Mechanisms of Prostate Cancer Metastasis
$435,646Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2025 · CA
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
$435,645Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Signal Transduction Therapy--Clinical
$435,614Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
LILRB modulates tumor microenvironment and promotes tumor progression
$435,587Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2018 · CA
Roles of long-non-coding RNA, XIST, in brain metastasis of breast cancer
$435,585Kounosuke Watabe · Wake Forest University Health Sciences · R01 · FY2019 · CA
DNA replication stress in cancer
$435,544Alessandro Vindigni · Washington University · R01 · FY2024 · CA
Signal Transduction Therapy--Basic Science
$435,505Elise C. Kohn · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
GENETIC INSTABILITY IN BREAST CANCER DEVELOPMENT: ROLE OF SP17
$435,481University Of Alabama At Birmingham · · FY2008 · Department of Defense
Prevalence effects in visual search: Theoretical and practical implications
$435,467Jeremy M Wolfe · Brigham And Women'S Hospital · R01 · FY2011 · EY
the mTOR translational control pathway in tamoxifen resistant ER+ breast cancer
$435,435Robert Schneider · New York University School Of Medicine · R01 · FY2020 · CA
Development of Natural Product Leads as Anticancer Therapeutics
$435,393John Beutler · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
PROTEOGLYCANS AND BASAL LAMINA STRUCTURE/FUNCTION
$435,387Children'S Hospital Boston · R01 · FY2001 · CA
Breast Cancer GWAS: Function and Environmental Interactions
$435,373Michael N Gould · University Of Wisconsin-Madison · R01 · FY2009 · ES
Specific and high-resolution ultrasound cancer imaging
$435,365Katherine W Ferrara · University Of California At Davis · R01 · FY2012 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$435,349Vanderbilt University · U10 · FY2002 · CA
Cohort Study of Genetic Susceptibility to Breast Cancer
$435,276Brigham And Women'S Hospital · R01 · FY2004 · CA
Skin & Immunology - Mitigation of Radiation and Combined Injury to the Skin
$435,250Edith M. Lord · University Of Rochester · U19 · FY2011 · AI
Drug repurposing in breast cancer
$435,224Rong Stephanie Huang · University Of Minnesota · R01 · FY2022 · CA
BRCA 1 and 2 and Breast Cancer Development
$435,222David Morse Livingston · Whitehead Institute For Biomedical Res · P01 · FY2013 · CA
Transforming Growth Factor-Beta Signal Transduction
$435,215Joan Massague · Sloan-Kettering Inst Can Research · R37 · FY2013 · CA
TARGET-GUIDED DEVELOPMENT OF SPECIFIC AKT INHIBITORS
$435,148Peter K Vogt · Scripps Research Institute, The · R01 · FY2007 · CA
A genomewide study of lung cancer in never smokers
$435,109Olga Gorlova · Dartmouth College · R01 · FY2014 · CA